8-K: Centene Reports Strong 2024 Results, Boosts 2025 Revenue Guidance

Centene Corporation announces its 2024 financial results, highlighting a 7% increase in adjusted diluted EPS and raising its 2025 premium and service revenues guidance by $4.0 billion.

Summary

• Centene Corporation reported its financial results for the fourth quarter and year ended December 31, 2024.
• The company's full year diluted EPS was $6.31, with an adjusted diluted EPS of $7.17, up 7% from $6.68 in 2023.
• Membership increased by 12% in the Marketplace and 50% in Medicare PDP compared to the fourth quarter of 2023.
• Centene executed $3.0 billion of share repurchases in 2024.
• The company increased its 2025 premium and service revenues guidance by $4.0 billion, driven by Medicaid revenue and better-than-expected membership performance in Medicare Advantage and PDP.
• Total revenues for 2024 were $163.071 billion, with premium and service revenues reaching $145.505 billion.
• The health benefits ratio (HBR) for the full year was 88.3%, while the SG&A expense ratio was 8.5%.

Sentiment

Score: 8

Explanation: The document presents a positive outlook with strong financial results, increased guidance, and strategic initiatives. While there are some challenges, the overall tone is optimistic and indicates confidence in the company's future performance.

Positives

• Centene's adjusted diluted EPS increased by 7% year-over-year.
• The company experienced significant membership growth in the Marketplace and Medicare PDP segments.
• Centene executed a substantial share repurchase program.
• The company increased its 2025 revenue guidance.
• Centene achieved a higher percentage of Medicare Advantage members in plans rated 3.5 stars or higher.
• The SG&A expense ratio decreased, indicating improved efficiency.
• Centene's subsidiary, Buckeye Health Plan, was selected by the Ohio Department of Medicaid to continue providing Medicare and Medicaid services for dually eligible individuals through a Fully Integrated Dual Eligible Special Needs Plan (FIDE SNP).

Negatives

• Medicaid membership decreased due to redeterminations.
• Cash flow used in operations for the fourth quarter of 2024 was $587 million, primarily driven by timing of receipt of net Part D receivables and higher state premium receivables for recent rate increases.
• The health benefits ratio (HBR) increased, driven by higher acuity in Medicaid resulting from the redetermination process as we continue to work with states to match rates with acuity and Medicare Star rating impacts.

Risks

• Medicaid redeterminations are negatively impacting membership.
• Higher acuity in Medicaid is increasing the health benefits ratio (HBR).
• The company faces risks related to predicting and managing health benefits expenses.
• Competition in the healthcare industry could impact growth and profitability.
• Changes in healthcare laws and regulations could affect Centene's business.
• Cyber-attacks or other data security incidents could disrupt operations and compromise sensitive information.

Future Outlook

Centene is increasing its 2025 premium and service revenues guidance range by $4.0 billion to a range of $158.0 billion to $160.0 billion and reiterates its 2025 GAAP diluted EPS guidance floor of greater than $6.19 and its 2025 adjusted diluted EPS guidance floor of greater than $7.25.

Management Comments

• Despite a year of unprecedented industry headwinds, Centene demonstrated significant operational improvements, strengthened our talent bench, and delivered on our financial commitments in 2024, said Chief Executive Officer of Centene, Sarah M. London.
• We enter 2025 with a strong, diversified platform and exciting opportunity to deliver value in each of our core businesses and to transform the health of communities we serve, one person at a time.

Industry Context

Centene's results reflect the ongoing challenges and opportunities within the managed care industry, including Medicaid redeterminations, Medicare Advantage star ratings, and the evolving healthcare landscape. The company's focus on operational improvements and strategic investments positions it to navigate these dynamics and capitalize on growth opportunities.

Comparison to Industry Standards

• Centene's performance can be compared to other major managed care organizations such as UnitedHealth Group (UNH), Anthem (ANTM), and Humana (HUM).
• Centene's HBR of 88.3% is within the typical range for managed care companies, but the increase indicates potential challenges in managing medical costs.
• The company's SG&A expense ratio of 8.5% demonstrates efficiency compared to some peers.
• The growth in Marketplace and Medicare PDP membership reflects Centene's success in these segments, aligning with industry trends.

Stakeholder Impact

• Shareholders will benefit from the increased EPS and share repurchase program.
• Members will have access to affordable and high-quality healthcare products.
• Employees will have opportunities for growth and development within the company.
• The company's community engagement initiatives will benefit local communities.

Next Steps

• Centene will continue to focus on operational improvements and strategic investments.
• The company will work to mitigate the impact of Medicaid redeterminations.
• Centene will aim to maintain or improve its Medicare Advantage star ratings.
• The company will execute its share repurchase program.

Key Dates